Comparing automatic and standard tourniquets for soldiers
Assessment of Automatic Tourniquets for Soldiers During Wartime as Part of Accelerated Research and Development
This study tests whether automatic tourniquets are easier to use and work better than standard tourniquets for stopping blood flow in healthy adults.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Medical Corps, Israel Defense Force Academic / other |
| Locations | 1 site (Ramat Gan) |
| Trial ID | NCT06123104 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the usability and performance of automatic tourniquets (AUT) compared to standard mechanical tourniquets (CAT) in healthy adults. Participants will apply both types of tourniquets on their upper and lower limbs, with a total of eight applications. The study will assess the effectiveness of blood flow occlusion and the ease of use of each tourniquet type. The results will help determine if AUTs can serve as a viable alternative to CATs in emergency situations.
Who should consider this trial
Good fit: Ideal candidates for this study are active service or active reserve soldiers without any disqualifying medical conditions.
Not a fit: Patients with muscle disorders, peripheral nerve disorders, skin diseases of the limbs, or a history of limb surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved trauma care for soldiers by providing a more effective and user-friendly tourniquet option.
How similar studies have performed: While there have been studies on tourniquet effectiveness, the specific comparison of automatic versus standard tourniquets in this context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: -Soldier in active service or active reserve service. Exclusion Criteria: * Muscle disorders * Peripheral nerve disorders * Skin diseases of the limbs * Limb surgery in the past * Rickets * Hypertension
Where this trial is running
Ramat Gan
- Tel hashomer — Ramat Gan, Israel (Recruiting)
Study contacts
- Principal investigator: Tomer Erlich, MD — Head of Medical innovation and R&D
- Study coordinator: Tomer Erlich, MD
- Email: tomer.erlich@gmail.com
- Phone: +972-3-737-9506
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.